DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Terapie Cellulari e Geniche per Neoplasie Solide Laboratory of Cell Biology and Advanced Cancer...

Slide 1Terapie Cellulari e Geniche per Neoplasie Solide Laboratory of Cell Biology and Advanced Cancer Therapy Department of Oncology & Hematology Hospital-University…

Education Small round cell_tumor_DR NARMADA

1. Moderator:-Dr. Poonam Nanwani Speaker:- Dr. Narmada Prasad Tiwari 2. Histologically, many of the pediatric neoplasms have more primitive origin characterized by sheets…

Documents Optimization of Pre-transplantation Conditions to Enhance the Efficacy of Mesenchymal Stem Cells

Int. J. Biol. Sci. 2015, Vol. 11 http://www.ijbs.com 324 IInntteerrnnaattiioonnaall JJoouurrnnaall ooff BBiioollooggiiccaall SScciieenncceess 2015; 11(3): 324-334. doi: 10.7150/ijbs.10567…

Documents Chapter 9 Chapter 9 Osteoblast Biology Copyright © 2013 Elsevier Inc. All rights reserved.

Chapter 9 Osteoblast Biology Copyright © 2013 Elsevier Inc. All rights reserved. Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 9.1 Lineage allocation of stem…

Documents RENAL TUMORS Renal BlockPathology Dept, KSU Renal Practical III.

RENAL TUMORS RENAL TUMORS Renal Block Pathology Dept , KSU Renal Practical III BENIGN RENAL TUMORS RARE Tumors Papillary Adenoma (SIZE very important) Fibroma/ Hamartoma…

Documents Terapie Cellulari e Geniche per Neoplasie Solide

Terapie Cellulari e Geniche per Neoplasie Solide Laboratory of Cell Biology and Advanced Cancer Therapy Department of Oncology & Hematology Hospital-University of Modena…

Documents Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases

Systemic autoimmune diseases arise from loss of self-tolerance and immune homeostasis between effector and regulator functions. There are many therapeutic modalities for

Documents The efficacy and safety of modified immunosuppressive therapy in patients with severe aplastic...

Original Article The efficacy and safety of modified immunosuppressive therapy in patients with severe aplastic anemia and transfusion-dependent non-severe aplastic anemia: